2021
DOI: 10.1038/s41380-021-01040-1
|View full text |Cite
|
Sign up to set email alerts
|

Update on GPCR-based targets for the development of novel antidepressants

Abstract: Traditional antidepressants largely interfere with monoaminergic transport or degradation systems, taking several weeks to have their therapeutic actions. Moreover, a large proportion of depressed patients are resistant to these therapies. Several atypical antidepressants have been developed which interact with G protein coupled receptors (GPCRs) instead, as direct targeting of receptors may achieve more efficacious and faster antidepressant actions. The focus of this review is to provide an update on how dist… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
21
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 34 publications
(22 citation statements)
references
References 294 publications
(385 reference statements)
0
21
0
1
Order By: Relevance
“…Many topics exhibit high embedding scores for neuronal functions including Neuronal Signal Transduction (GO:0023041), Central Nervous System Projection Neuron Axonogenesis (GO:0021952), and Branchiomotor Neuron Axon Guidance (GO:0021785). Interestingly, Topic 98 in MDD-coding genes only and Topics 22, 51 in MDD-all genes involve Adenylate Cyclase Modulating G-protein Coupled Receptors (GPCRs) Signaling (GO:0007188), which is the target of several recently-developed antidepressant drugs 52 .…”
Section: Scalabilitymentioning
confidence: 99%
“…Many topics exhibit high embedding scores for neuronal functions including Neuronal Signal Transduction (GO:0023041), Central Nervous System Projection Neuron Axonogenesis (GO:0021952), and Branchiomotor Neuron Axon Guidance (GO:0021785). Interestingly, Topic 98 in MDD-coding genes only and Topics 22, 51 in MDD-all genes involve Adenylate Cyclase Modulating G-protein Coupled Receptors (GPCRs) Signaling (GO:0007188), which is the target of several recently-developed antidepressant drugs 52 .…”
Section: Scalabilitymentioning
confidence: 99%
“…Many topics exhibit high embedding scores for neuronal functions including Neuronal Signal Transduction (GO:0023041), Central Nervous System Projection Neuron Axonogenesis (GO:0021952), and Branchiomotor Neuron Axon Guidance (GO:0021785). Interestingly, Topic 98 in MDD -coding genes only and Topics 22, 51 in MDD -all genes involve Adenylate Cyclase Modulating G-protein Coupled Receptors (GPCRs) Signaling (GO:0007188), which is the target of several recently-developed antidepressant drugs [53].…”
Section: Pathway-informed Scetm Topicsmentioning
confidence: 99%
“…Thus, receptor activation is inherently an allosteric process that involves inter-subunit and inter-domain cooperativity. In the class C family, metabotropic glutamate receptors (mGluRs) are responsible for mediating the slow neuromodulatory effects of glutamate to tune synaptic excitability and transmission (Niswender & Conn, 2010; Pin & Bettler, 2016), making them promising therapeutic targets for treating a range of neurological and psychiatric disorders (Conn et al, 2009; Foster & Conn, 2017; Mantas et al, 2021). Based on structural (Doré et al, 2014; Du et al, 2021; Seven et al, 2021; Wu et al, 2014) and mutagenesis (Farinha et al, 2015; Gregory & Conn, 2015; Lundström et al, 2011) studies, the primary mGluR allosteric binding sites were determined to be located within the 7TM domain bundles.…”
Section: Introductionmentioning
confidence: 99%